Tarcocimab Tedromer
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Tarcocimab Tedromer, covering 2025-03-30 to 2026-04-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK [Phase 3]